Gp96 has innate capacity of binding tumor-associated antigens (peptides), thereby forming a gp96-peptides complex that can be taken up by antigen-presenting cells, such as dendritic cells, and then elicit both innate and adaptive antitumor immune response (13). Here, HSP90B1 is linked to neoplasm.